Related Experiment Video
Updated: Sep 16, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
A comparative analysis of three pharmacovigilance system assessment tools
Muhammad Akhtar Abbas Khan1,2, Jude Nwokike3, Asim Rauf2
1Department of Public Health, Health Services Academy, Islamabad, Pakistan.
Background:
Three key tools are currently available for assessing pharmacovigilance systems at the national level: the Indicator-Based Pharmacovigilance Assessment Tool (IPAT), the World Health Organization (WHO) Pharmacovigilance Indicators, and the Vigilance Module of the WHO Global Benchmarking Tool (GBT). These instruments are designed to evaluate the functionality and performance of national regulatory authorities within the context of their respective pharmacovigilance systems.
Objectives:
This study aims to identify, analyze, and compare the core characteristics and operational features of these pharmacovigilance assessment tools to better understand their scope, application, and limitations.
Methodology:
A structured document analysis was conducted on the three identified tools. The content was systematically reviewed, categorized, and synthesized to facilitate a comparative evaluation of its design, focus areas, and assessment criteria.
Results:
The analysis revealed that the available tools encompass a broad spectrum of indicators targeting different dimensions of pharmacovigilance systems, such as infrastructure, processes, and outcomes. However, exclusive reliance on a single tool may offer a limited perspective, potentially overlooking critical components of a national pharmacovigilance framework.
Conclusion:
This study underscores the heterogeneity of existing pharmacovigilance assessment tools and emphasizes the importance of context-specific adaptation. A tailored approach, involving the strategic selection or integration of tools, is recommended to ensure a comprehensive and accurate evaluation of national pharmacovigilance systems.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact